TECH BUYER Apr 2022 - IDC Perspective - Doc # US47726621
Infosys and Top Pharma Bring Digital Transformation to Drug Manufacturing Data
Abstract
This IDC Perspective highlights how Infosys and a top 20 global pharmaceutical company bring digital transformation to drug manufacturing data. Analytics and data operations in biopharmaceutical manufacturing hold great potential for speeding lifesaving and life-improving drugs to manufacture while improving quality and efficiency. As pressure increases on drug companies to lower prices and costs, digital transformation in manufacturing data analytics offers a great opportunity to accomplish both.
"Life science companies are beginning to realize the fruits of their investments in digital transformation on the manufacturing floor by improving access to real-time data and providing platforms and analytics tools that generate valuable insights, allowing actions that improve quality and save time," according to Michael Townsend, research director for Life Sciences Commercial Strategies at IDC Health Insights
Coverage
Subscriptions Covered
IDC Health Insights: Worldwide Life Sciences Commercial Strategies
Companies Covered
Regions Covered
Topics Covered
Analytic applications, Big data analytics and discovery, Digital transformation, IT consulting services, Infrastructure as a service, Systems integration services, Technology buyer
Vertical Markets
Health treatment strategies, Knowledge-based medicine
Content
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.